Fontenot AP - Search Results

1

Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.

Chou YK, Edwards DM, Weinberg AD, Vandenbark AA, Kotzin BL, Fontenot AP, Burrows GG. Chou YK, et al. Among authors: fontenot ap. J Immunol. 2005 Apr 1;174(7):4316-24. doi: 10.4049/jimmunol.174.7.4316. J Immunol. 2005. PMID: 15778396

2

Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.

Fontenot AP, Keizer TS, McCleskey M, Mack DG, Meza-Romero R, Huan J, Edwards DM, Chou YK, Vandenbark AA, Scott B, Burrows GG. Fontenot AP, et al. J Immunol. 2006 Sep 15;177(6):3874-83. doi: 10.4049/jimmunol.177.6.3874. J Immunol. 2006. PMID: 16951350

3

Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung.

Fontenot AP, Maier LA, Canavera SJ, Hendry-Hofer TB, Boguniewicz M, Barker EA, Newman LS, Kotzin BL. Fontenot AP, et al. J Immunol. 2002 Apr 1;168(7):3627-34. doi: 10.4049/jimmunol.168.7.3627. J Immunol. 2002. PMID: 11907128

4

Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.

Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP. Bill JR, et al. Among authors: fontenot ap. J Immunol. 2005 Nov 15;175(10):7029-37. doi: 10.4049/jimmunol.175.10.7029. J Immunol. 2005. PMID: 16272364

5

Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.

Fontenot AP, Edwards DM, Chou YK, Mack DG, LaTocha D, Vandenbark AA, Burrows GG. Fontenot AP, et al. Eur J Immunol. 2006 Apr;36(4):930-9. doi: 10.1002/eji.200526075. Eur J Immunol. 2006. PMID: 16552706 Free article.

6

Identification of pathogenic T cells in patients with beryllium-induced lung disease.

Fontenot AP, Falta MT, Freed BM, Newman LS, Kotzin BL. Fontenot AP, et al. J Immunol. 1999 Jul 15;163(2):1019-26. J Immunol. 1999. PMID: 10395700

7

Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.

Fontenot AP, Kotzin BL. Fontenot AP, et al. Tissue Antigens. 2003 Dec;62(6):449-58. doi: 10.1046/j.1399-0039.2003.00160.x. Tissue Antigens. 2003. PMID: 14617028 Review.

8

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Fontenot AP, et al. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12717-22. doi: 10.1073/pnas.220430797. Proc Natl Acad Sci U S A. 2000. PMID: 11050177 Free PMC article.

9

Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.

Fontenot AP, Newman LS, Kotzin BL. Fontenot AP, et al. Clin Immunol. 2001 Jul;100(1):4-14. doi: 10.1006/clim.2001.5053. Clin Immunol. 2001. PMID: 11414740 Review. No abstract available.

10

Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.

Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL. Fontenot AP, et al. J Clin Invest. 2002 Nov;110(10):1473-82. doi: 10.1172/JCI15846. J Clin Invest. 2002. PMID: 12438445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters